Indonesia’s Bio Farma To Produce 20 Million Bird Flu Doses In 2011
This article was originally published in PharmAsia News
Executive SummaryIndonesia's state-owned PT Bio Farma expects to be a large producer of avian influenza vaccines for humans within the next three years. The company expects to begin making 20 million doses in 2011. A seasonal bird flu vaccine is to be produced next year, backed by a government investment of $43 million. The plans call for the 20 million doses to be held for domestic consumption. (Click here for more
You may also be interested in...
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.